India Contract Cell and Gene Therapy Manufacturing Market (2026-2032) Outlook | Trends, Analysis, Share, Industry, Forecast, Size, Revenue, Companies, Growth, Value

Name: India Contract Cell and Gene Therapy Manufacturing Market Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Vector (Viral Vector, Non-viral Vector), By Indication (Cancer, Neurological Diseases, Hepatological Diseases, Others) And Competitive Landscape

Product Code: ETC070003	Publication Date: Jun 2023	Updated Date: Jun 2026	Product Type: Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 70	No. of Figures: 35	No. of Tables: 5

India Contract Cell and Gene Therapy Manufacturing Market Size, Share & Growth Rate

The India Contract Cell and Gene Therapy Manufacturing Market was estimated at USD 1013 Million in 2025 and is projected to reach USD 1441 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This upward trajectory is primarily driven by escalating investments from government bodies and private sectors focused on innovative cancer treatments. Additionally, the surge in awareness regarding cell and gene therapies is propelling demand as more patients seek advanced therapeutic options.

India Contract Cell and Gene Therapy Manufacturing Market Year-wise Growth Rate and Key Drivers

This graph highlights how the India Contract Cell and Gene Therapy Manufacturing Market has steadily grown over the years, supported by major growth factors.

India Contract Cell and Gene Therapy Manufacturing Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

Year	Growth Rate	Major Drivers
2021	-3.2%	Increasing industrial automation investments
2022	8.8%	Growing renewable energy integration projects
2023	7.8%	Rising electricity demand across industries
2024	7.3%	Government infrastructure modernization initiatives
2025	7.3%	Growing urbanization and commercial development
2026	7.8%	Increasing smart city development projects
2027	6.1%	Rapid growth in telecom and data center sectors
2028	6.3%	Expansion of manufacturing activities
2029	6.0%	Expansion of manufacturing activities
2030	6.0%	Growing renewable energy integration projects
2031	6.1%	Rapid growth in telecom and data center sectors
2032	6.4%	Expansion of commercial construction activities

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.

India Contract Cell and Gene Therapy Manufacturing Market Synopsis

In recent years, the India Contract Cell and Gene Therapy Manufacturing Market has experienced notable momentum, spurred by a supportive ecosystem and a surge in research activity. Moving forward, the market is poised for significant expansion, driven by increasing healthcare needs and the nation's robust talent pool.

The landscape is evolving rapidly as stakeholders, including academic institutions and private companies, converge on advanced therapies that leverage local resources. The favorable regulatory environment also enhances the potential for growth, making India an attractive hub for contract manufacturing in this specialized sector.

India Contract Cell and Gene Therapy Manufacturing Market Key Takeaways

Significant growth potential driven by increasing investments in advanced cancer treatment.
Rising consumer awareness is expanding the market's scope across various therapeutic areas.
A favorable regulatory environment facilitates access to diverse raw materials at competitive prices.
India's qualified workforce plays a crucial role in sustaining innovation in cell and gene therapies.
The market is expected to evolve with continued government support and funding initiatives.

Evaluation of Restraints in India Contract Cell and Gene Therapy Manufacturing Market

Despite its promising outlook, the India Contract Cell and Gene Therapy Manufacturing Market faces several constraints. Limited public awareness about the complexities of these therapies can hinder broader acceptance. Additionally, regulatory challenges related to the rapid pace of technology and research in the industry may slow down the adoption of innovative treatments. Furthermore, the market must navigate the intricacies of securing adequate funding for research and development, which can be a barrier for smaller entities entering the space.

India Contract Cell and Gene Therapy Manufacturing Market Trends

Current trends indicate a strong shift towards personalized medicine, with a growing emphasis on tailoring therapies to individual patient needs. Additionally, advancements in technology are enabling more efficient manufacturing processes, thereby reducing costs and enhancing product accessibility. The integration of artificial intelligence in research and development is also gaining traction, improving the speed and effectiveness of clinical trials.

India Contract Cell and Gene Therapy Manufacturing Market Opportunities

The market is brimming with growth opportunities, particularly in the development of therapies targeting chronic diseases prevalent in India. Investment in infrastructure to support advanced manufacturing capabilities presents a significant avenue for growth. Moreover, collaborative partnerships between government, academia, and private sectors can drive innovation and expedite the rollout of new therapies, ultimately benefiting the healthcare landscape.

Government Initiatives in the India Contract Cell and Gene Therapy Manufacturing Market

The Indian government has ramped up its commitment to fostering advancements in cell and gene therapy through various initiatives. Investment in laboratory infrastructure and grants aimed at supporting innovative projects have been prioritized. These efforts are designed to catalyze research activity and enhance the country's capability to produce cutting-edge therapies using local resources.

Future Insights of the India Contract Cell and Gene Therapy Manufacturing Market

Looking ahead to 2026-2032, the India Contract Cell and Gene Therapy Manufacturing Market is on a trajectory of substantial growth. As chronic diseases continue to rise, the demand for novel therapies will increase, pushing the market forward. With continued investments in research and a robust framework supporting innovation, India is well-positioned to become a global leader in the cell and gene therapy manufacturing landscape.

India Contract Cell and Gene Therapy Manufacturing Market Latest Developments (May 2025 - June 2026)

Recent developments in the industry reflect a strong alignment towards enhancing operational capabilities and expanding research initiatives. Key stakeholders have initiated collaborations aimed at improving the efficiency of cell and gene therapy manufacturing processes. Additionally, ongoing governmental support continues to bolster funding for critical research and infrastructure, positioning India favorably in the global arena.

India Contract Cell and Gene Therapy Manufacturing Market - Key Attractiveness of the Report

10 Years of Market Numbers
Historical Data Starting from 2022 to 2025
Base Year: 2025
Forecast Data until 2032
Key Performance Indicators Impacting the Market
Major Upcoming Developments and Projects

Key Highlights of the Report:

India Contract Cell and Gene Therapy Manufacturing Market Outlook
Market Size of India Contract Cell and Gene Therapy Manufacturing Market, 2025
Forecast of India Contract Cell and Gene Therapy Manufacturing Market, 2032
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Revenues & Volume for the Period 2022-2032F
India Contract Cell and Gene Therapy Manufacturing Market Trend Evolution
India Contract Cell and Gene Therapy Manufacturing Market Drivers and Challenges
India Contract Cell and Gene Therapy Manufacturing Price Trends
India Contract Cell and Gene Therapy Manufacturing Porter's Five Forces
India Contract Cell and Gene Therapy Manufacturing Industry Life Cycle
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Vector for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Viral Vector for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Non-viral Vector for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Indication for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Cancer for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Neurological Diseases for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Hepatological Diseases for the Period 2022-2032F
Historical Data and Forecast of India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2022-2032F
India Contract Cell and Gene Therapy Manufacturing Import Export Trade Statistics
Market Opportunity Assessment By Vector
Market Opportunity Assessment By Indication
India Contract Cell and Gene Therapy Manufacturing Top Companies Market Share
India Contract Cell and Gene Therapy Manufacturing Competitive Benchmarking By Technical and Operational Parameters
India Contract Cell and Gene Therapy Manufacturing Company Profiles
India Contract Cell and Gene Therapy Manufacturing Key Strategic Recommendations

India Contract Cell and Gene Therapy Manufacturing Market - Frequently Asked Questions

What are the key drivers behind the growth of the India Contract Cell and Gene Therapy Manufacturing Market?

What is the projected market size for the India Contract Cell and Gene Therapy Manufacturing Market?

How is the regulatory environment influencing this market?

What are the emerging trends impacting the demand for cell and gene therapies?

What growth opportunities exist for new entrants in this market?

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Contract Cell and Gene Therapy Manufacturing Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2022 & 2032F

3.3 India Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 India Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2022 & 2032F

3.6 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2022 & 2032F

4 India Contract Cell and Gene Therapy Manufacturing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Growth in research and development activities in cell and gene therapy

4.2.3 Government initiatives to promote biotechnology and life sciences sector in India

4.3 Market Restraints

4.3.1 High cost of cell and gene therapy manufacturing processes

4.3.2 Limited skilled workforce in specialized manufacturing techniques

4.3.3 Stringent regulatory requirements and compliance standards in the biopharmaceutical industry

5 India Contract Cell and Gene Therapy Manufacturing Market Trends

6 India Contract Cell and Gene Therapy Manufacturing Market, By Types

6.1 India Contract Cell and Gene Therapy Manufacturing Market, By Vector

6.1.1 Overview and Analysis

6.1.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2022-2032F

6.1.3 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2022-2032F

6.1.4 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2022-2032F

6.2 India Contract Cell and Gene Therapy Manufacturing Market, By Indication

6.2.1 Overview and Analysis

6.2.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2022-2032F

6.2.3 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2022-2032F

6.2.4 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2022-2032F

6.2.5 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2022-2032F

7 India Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics

7.1 India Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries

7.2 India Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries

8 India Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators

8.1 Number of new partnerships and collaborations in the cell and gene therapy manufacturing sector

8.2 Investment in infrastructure and technology upgrades by contract manufacturing organizations

8.3 Number of clinical trials and research studies involving cell and gene therapies in India

9 India Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment

9.1 India Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2022 & 2032F

9.2 India Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2022 & 2032F

10 India Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape

10.1 India Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2025

10.2 India Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Contract Cell and Gene Therapy Manufacturing Market

Asia Contract Cell and Gene Therapy Manufacturing Market

Asia Pacific Contract Cell and Gene Therapy Manufacturing Market

Estonia Contract Cell and Gene Therapy Manufacturing Market

Ethiopia Contract Cell and Gene Therapy Manufacturing Market

Europe Contract Cell and Gene Therapy Manufacturing Market

Fiji Contract Cell and Gene Therapy Manufacturing Market

Finland Contract Cell and Gene Therapy Manufacturing Market

Gabon Contract Cell and Gene Therapy Manufacturing Market

Global Contract Cell and Gene Therapy Manufacturing Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here